Skip to main content
Jessie Torgersen, MD, Infectious Disease, Philadelphia, PA

JessieTorgersenMDMHS, MSCE, FIDSA

Infectious Disease Philadelphia, PA

HIV/AIDS Medicine

Physician

Dr. Torgersen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Torgersen's full profile

Already have an account?

  • Office

    51 N 39th St
    Philadelphia, PA 19104

Summary

  • Dr. Jessie Torgersen is an infectious disease specialist in Philadelphia, PA and is affiliated with multiple hospitals in the area, including Penn Presbyterian Medical Center, Hospital of the University of Pennsylvania, Philadelphia Veterans Affairs Medical Center, and Good Shepherd Penn Partners Specialty Hospital at Rittenhouse. She received her medical degree from Wayne State University School of Medicine and has been in practice 12 years. She specializes in HIV/AIDS medicine and is experienced in infective endocarditis, hepatitis B, hepatitis C, and non-alcoholic fatty liver disease among people with HIV.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Infectious Disease, 2013 - 2015
  • Emory University School of Medicine
    Emory University School of MedicineResidency, Internal Medicine, 2010 - 2013
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 2010
  • University of Pennsylvania
    University of PennsylvaniaMSCE
  • Johns Hopkins Bloomberg School of Public Health
    Johns Hopkins Bloomberg School of Public HealthMHS
  • University of California, Santa Barbara
    University of California, Santa BarbaraBS, BA

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2013 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Enhancing Hepatitis B Care Competency through Project ECHO: A Program Evaluation  
    Freeland C, Bruckbauer J, Qureshi A, Huynh K, Rutland M, Fenkel JM, Torgersen J, Rothstein K, Gish R, Cohen C, J Dig Dis Hepatol, 12/27/2023

Books/Book Chapters

Abstracts/Posters

  • Clinic Screening for Adverse Childhood Experiences among Persons with HIV: a Pilot Project. IDWeek 2019
    Anand P, Carter B, Bronstein A, Schwartz A, Harrington B, Wilson J, Metzger D, Short W, Torgersen J, ID Week, Washington, DC, 10/3/2019
  • Adverse Childhood Experiences (ACEs) Screening and Referral to Care in an HIV Primary Care Clinic: A Pilot Project in Quality Improvement
    Anand P, Harrington B, Carter B, Bronstein A, Schwartz A, Metzger D, Short W, Torgersen J, 2019 End AIDS: The HIV Prevention and Education Summit, Philadelphia, PA, 6/11/2019
  • Elimination of Hepatitis C Virus in HIV-Coinfected Patients in a Viral Hepatitis Center: A Multi-Disciplinary Approach
    Binkley A, Torgersen J, Gilmore J, O’Neal J, Saine ME, Russell R, Short W, Lo Re III V, American Conference for the Treatment of HIV, Miami, FL, 4/11/2019
  • Join now to see all

Lectures

  • Hepatitis C Diagnosis and Treatment 
    Penn Medicine Infectious Disease Update for Primary Care Providers - 5/20/2022
  • Hepatocellular Risk in HIV 
    Yale Virus and Other Infection-Related Cancers Summit. Yale University School of Medicine - 4/30/2019
  • HIV Viremia and Low CD4+ Cell Count Predict Development of Hepatocellular Carcinoma in Early But Not Advanced Liver Fibrosis 
    Conference on Retroviruses and Opportunistic Infections - 3/6/2019
  • Join now to see all

Press Mentions

  • Listen to "Liver Cancer Screening: A New Tool for Improved-Detection
    Listen to "Liver Cancer Screening: A New Tool for Improved-DetectionNovember 8th, 2024
  • Q&A: Emphasizing Transmission & Prevention Key to Reduce HCV Reinfection in MSM with HIV
    Q&A: Emphasizing Transmission & Prevention Key to Reduce HCV Reinfection in MSM with HIVOctober 29th, 2024
  • Most Potentially Hepatotoxic Meds Revealed: Real-World Data Analysis
    Most Potentially Hepatotoxic Meds Revealed: Real-World Data AnalysisJuly 16th, 2024
  • Join now to see all

Grant Support

  • Use of Deep Learning Algorithms to Enable Evaluation of the Determinants and Outcomes of Hepatic Steatosis, by HIV StatusNational Institute of Diabetes and Digestive and Kidney Disease2022–2027

Committees

  • Co-Chair, IDSA Grants for Emerging Researchers/Clinicians Mentorship Program 2024 - Present
  • Member, AASLD/IDSA HCV Guidance Panel 2023 - Present

Professional Memberships